tiprankstipranks
Trending News
More News >
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD

ACADIA Pharmaceuticals (ACAD) Revenue

Compare
2,332 Followers

ACADIA Pharmaceuticals Revenue

ACADIA Pharmaceuticals had a revenue of 259.60M in the quarter ending Dec 31, 2024, with 3.67%. This bring the company's revenue in the last twelve months to 957.80M, Decreased 3.07%. In the fiscal year ending Dec 31, 2024, ACADIA Pharmaceuticals had annual revenue of 957.80M with 31.85% growth.
Revenue (ttm)
957.80M
Revenue Growth
22.42%
P/S Ratio
3.84
Revenue/Employee
$1,466,764
Employees
653
Market Cap
$3.68B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
957.80M231.36M+31.85%
Dec 31, 2023
726.44M209.20M+40.45%
Dec 31, 2022
517.24M33.09M+6.83%
Dec 31, 2021
484.14M42.39M+9.60%
Dec 31, 2020
441.75M102.68M+30.28%
Dec 31, 2019
339.08M115.27M+51.50%
Dec 31, 2018
223.81M98.91M+79.19%
Dec 31, 2017
124.90M107.57M+620.68%
Dec 31, 2016
17.33M17.27M+28,311.48%
Dec 31, 2015
61.00K-59.00K-49.17%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis